-+ 0.00%
-+ 0.00%
-+ 0.00%

PFIZER: SAFETY PROFILE FOR PADCEV PLUS PEMBROLIZUMAB WAS CONSISTENT WITH KNOWN PROFILE OF TREATMENT REGIMEN

路透·12/17/2025 11:45:00

登錄查看新聞詳情